BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 29054966)

  • 1. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
    Wang B; Tang Z; Gong H; Zhu L; Liu X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
    Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
    BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT).
    Sun Y; Wu P; Sun Y; Sharopov FS; Yang Q; Chen F; Wang P; Liang Z
    Biochem Biophys Res Commun; 2018 Jan; 495(1):911-921. PubMed ID: 29127013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
    Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Wan J; Liu Y; Long F; Tian J; Zhang C
    Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.